Portfolio company
Quris
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Quris develops a platform using organ-on-a-chip technology and artificial intelligence to predict the safety and efficacy of drug candidates for pharmaceutical companies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cellbox Labs
This company develops automated organ-on-chip platforms for pharmaceutical firms to perform precise drug discovery and testing without using animal models.
VeriSIM Life
The company develops an artificial intelligence platform to simulate drug candidate behaviour and predict clinical success for pharmaceutical and biotechnology organisations.
NETRI
NETRI develops organ-on-chip devices and AI algorithms for pharmaceutical and cosmetic companies to predict drug toxicity and efficacy using human cell models.
VitrofluidiX
VitrofluidiX develops an integrated organ-on-a-chip platform for pharmaceutical companies and research institutions to conduct predictive human biology testing without animal models.
QuantHealth
This company develops an artificial intelligence platform for clinical trial simulation and drug-patient outcome prediction for the pharmaceutical and biotechnology industries.
QuirieGen
This company develops single-cell multi-omic technologies and AI models for drug discovery and development within the pharmaceutical sector.
Toxometris.ai
This company provides an artificial intelligence platform for predicting chemical toxicity and drug properties for pharmaceutical and biotechnology researchers.
Revalia
This company provides a platform for testing drug candidates on functional human organs to provide preclinical data for pharmaceutical and biotechnology firms.
